An unprecedented $3 million was raised to support lupus research through two fundraising efforts, the 2016 Walk with Us to Cure Lupus program…
Articles by Ines Martins, PhD
Mallinckrodt Pharmaceuticals announced the enrollment of the first patients in the company’s Phase 4 clinical trial of H.P. Acthar Gel…
Bilingual groups providing support and education to systemic lupus erythematosus (SLE) patients and their family members  — people who live in…
Anthera Pharmaceuticals’ CHABLIS-SC1 Phase 3 clinical trial of its investigational therapy blisibimod did not meet its primary endpoint. After 52…
Neovacs announced that it has enrolled the first patient in the United States in its expanded, Phase 2b global clinical trial…
Merck KGaA announced that it will present two posters showing positive clinical data for its drug candidate atacicept, a recombinant fusion protein for the treatment…
An independent Data Safety Monitoring Board (DSMB) established by Biotest has recommended the company begin part 2 of its Phase…
The Oklahoma Medical Research Foundation (OMRF), an independent non-profit biomedical research institute, will enter a new research collaboration with…
The Lupus Foundation of America (LFA)Â announced the launch of its latest crowdfunding campaign to raise money for lupus research:…
Georgia on my mind … So much has happened in the last two weeks I have no…